journal article·2020-09

PVA/anionic collagen membranes as drug carriers of ciprofloxacin hydrochloride with sustained antibacterial activity and potential use in the treatment of ulcerative keratitis

Jorge Humberto Unas Daza, Gabriela Marinho Righetto, Marco Vinicius Chaud, Virginia da Conceição Amaro Martins, Ilana Lopes Baratella da Cunha Camargo, Ana Maria de Guzzi Plepis

Publisher page

Abstract

Devices such as contact lenses and collagen shields have been used to improve the antibiotic bioavailability of eye drops formulations in the treatment of ulcerative keratitis. Nevertheless, these devices are not sustained drug delivery systems, and a combination with eye drops is necessary. In animal patients, it requires constant supervision by trained personnel to avoid device loss, which increases the cost of treatment. In this study, PVA/anionic collagen membranes containing ciprofloxacin or tobramycin were prepared using two different methodologies, and the release, physical and antimicrobial properties were evaluated. The membrane containing ciprofloxacin was selected as a sustained drug delivery system with antibacterial activity against Staphylococcus aureus and Escherichia coli during 48 h. Despite to be opaque, due to its heterogeneous morphology, this membrane had the adequate mechanical strength, water content, hydrophilicity, water vapor permeability, and surface pH to interact with cornea without causing discomfort. In the surface of this membrane it was observed dispersed collagen fibrils which could serve as a substrate for corneal proteinases, contributing to the reduction in stromal damage and enhancing the epithelium regeneration. These results encourage the idea these membranes are new cost-effective and safe alternatives to treat corneal ulcers in animal patients.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Corneal Surgery and Treatments · Ocular Surface and Contact Lens · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Biochemistry and Biomaterials, São Carlos Institute of Chemistry, University of São Paulo, São Carlos, Brazil

Laboratory of Epidemiology and Molecular Microbiology (LEMiMo), São Carlos Institute of Physics, University of São Paulo, São Carlos, Brazil

Laboratory of Biomaterial and Nanotechnology, University of Sorocaba, Sorocaba, Brazil

References (45)

Show source-provided references
1. 10.1111/j.1748-5827.1984.tb00444.x10.1111/j.1748-5827.1984.tb00444.x ↗
2. Gilger B, Bentley E and Ollivier FJ. Diseases and surgery of the canine cornea and sclera. In: Gelatt KN (ed) Veterinary ophthalmology . Iowa: Blackwell Publishing, 2007, pp. 690–752.
3. 10.1590/S0102-0935200600060000810.1590/S0102-09352006000600008 ↗
4. Gelatt KN. Canine cornea: diseases and surgery. In: Gelatt KN (ed) Essentials of veterinary ophthalmology . Oxford, UK: John Wiley, 2014. pp. 216–248.10.1002/9781118910337.ch11 ↗
5. 10.1208/s12248-010-9183-310.1208/s12248-010-9183-3 ↗
6. 10.1007/s11095-008-9694-010.1007/s11095-008-9694-0 ↗
7. 10.1089/jop.2012.021210.1089/jop.2012.0212 ↗
8. 10.1016/S0886-3350(88)80007-510.1016/S0886-3350(88)80007-5 ↗
9. 10.1016/S0039-6257(01)00304-610.1016/S0039-6257(01)00304-6 ↗
10. Robin JB · Investig Ophthalmol Vis Sci · 1990 · 31 · 1294
11. Li G · Int J Clin Exp Med · 2015 · 8 · 12949
12. Chak V · Int J Pharm Teach Pract · 2013 · 4 · 811
13. 10.1016/S0378-5173(01)00691-310.1016/S0378-5173(01)00691-3 ↗
14. 10.1163/156856294X0010310.1163/156856294X00103 ↗
15. 10.1080/00222348.2012.66006010.1080/00222348.2012.660060 ↗
16. 10.1016/j.foodhyd.2007.10.00110.1016/j.foodhyd.2007.10.001 ↗
17. 10.1016/j.apsusc.2017.03.21610.1016/j.apsusc.2017.03.216 ↗
18. 10.1007/BF0012559010.1007/BF00125590 ↗
19. 10.1016/j.matchemphys.2013.03.04910.1016/j.matchemphys.2013.03.049 ↗
20. 10.1016/S0141-3910(03)00232-510.1016/S0141-3910(03)00232-5 ↗
21. 10.1016/0142-9612(95)99641-X10.1016/0142-9612(95)99641-X ↗
22. 10.1016/j.molliq.2008.06.00510.1016/j.molliq.2008.06.005 ↗
23. 10.1021/bm000118810.1021/bm0001188 ↗
24. 10.1046/j.1525-1594.2000.06517.x10.1046/j.1525-1594.2000.06517.x ↗
25. 10.1002/jps.260073093010.1002/jps.2600730930 ↗
26. CLSI. Performance standards for antimicrobial susceptibility testing. 27th ed. Approved Standard M100. Wayne, PA: Clinical and Laboratory Standards Institute. DOI: 10.1108/08876049410065598.10.1108/08876049410065598 ↗
27. 10.1128/AAC.28.3.38110.1128/AAC.28.3.381 ↗
28. 10.3390/molecules2211189810.3390/molecules22111898 ↗
29. 10.1016/j.ijpharm.2016.01.06910.1016/j.ijpharm.2016.01.069 ↗
30. 10.1117/1.JNP.7.07359010.1117/1.JNP.7.073590 ↗
31. Giraldez MJ and Yebra-Pimentel E. Hydrogel contact lenses surface roughness and bacterial adhesion. In: Adio A (ed) Ocular diseases. London: IntechOpen, 2012, pp. 95–120.
32. 10.1016/j.actbio.2013.08.03310.1016/j.actbio.2013.08.033 ↗
33. 10.1001/archopht.1988.0106014087803210.1001/archopht.1988.01060140878032 ↗
34. 10.3109/02713683.2015.110759110.3109/02713683.2015.1107591 ↗
35. 10.1007/s10856-013-5121-010.1007/s10856-013-5121-0 ↗
36. 10.1002/jbm.b.3376210.1002/jbm.b.33762 ↗
37. Jacobs DS, Johns LK and Le H-G. Contact lenses for ocular surface disease. In: Holland EJ, Mannis MJ, Lee WB (eds) Ocular surface disease: cornea, conjunctiva and tear film. London: W.B. Saunders, 2013, pp. 283–291.10.1016/B978-1-4557-2876-3.00035-3 ↗
38. 10.1016/j.clae.2004.08.00210.1016/j.clae.2004.08.002 ↗
39. 10.1016/j.preteyeres.2015.07.00110.1016/j.preteyeres.2015.07.001 ↗
40. 10.1002/jbm.b.3005110.1002/jbm.b.30051 ↗
41. 10.1016/S1056-8719(98)00027-610.1016/S1056-8719(98)00027-6 ↗
42. 10.4103/0250-474X.2963110.4103/0250-474X.29631 ↗
43. 10.3109/03639045.2010.50253310.3109/03639045.2010.502533 ↗
44. 10.1016/j.ajps.2013.12.00210.1016/j.ajps.2013.12.002 ↗
45. Sueke H, Shankar J, Neal TJ, et al. New developments in antibacterial chemotherapy for bacterial keratitis. In: Reinhard T and Larkin F (eds) Corneal disease . New York: Springer Berlin Heidelberg, 2013. pp. 19–35.10.1007/978-3-642-28747-3_2 ↗